secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001641172-25-016000
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals to report FY2025 results June 30, host call July 1
------------------------------------------------------------------------

- FY2025 (ended March 31, 2025) financial results to be released June 30, 2025.
- Conference call to discuss results on July 1, 2025 at 11:30 AM EDT.
- Dial-in: 1-800-346-7359 (domestic) or 1-973-528-0008 (international); ID 98840.
- Shareholders can email questions to dianne@elitepharma.com by respective deadlines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000164117225016000/0001641172-25-016000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000164117225016000/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer